t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: possible role of COX2.
BACKGROUND: HER2-targeted therapy with the monoclonal antibody trastuzumab (Herceptin) has improved disease-free survival for women diagnosed with HER2-positive breast cancers; however, treatment resistance and disease progression are not uncommon. Current data suggest that resistance to treatment i...
Main Authors: | Margaret Flowers, Patricia A Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2671134?pdf=render |
Similar Items
-
The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.
by: Lina Ekerljung, et al.
Published: (2012-01-01) -
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks.
by: Iulia M Lazar, et al.
Published: (2022-01-01) -
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks
by: Iulia M. Lazar, et al.
Published: (2022-01-01) -
Retracted: Effects of silver nanoparticles coated with anti‐HER2 on irradiation efficiency of SKBR3 breast cancer cells
by: Shahin Aghamiri, et al.
Published: (2019-10-01) -
Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer
by: Anna Kokot, et al.
Published: (2024-03-01)